Safety, Efficacy, and Persistence of Long ‐Term Mirabegron Treatment for Overactive Bladder in the Daily Clinical Setting: Interim (1‐Year) Report from a Japanese Post‐Marketing Surveillance Study

LUTS: Lower Urinary Tract Symptoms, EarlyView.

Source: LUTS: Lower Urinary Tract Symptoms - August 1, 2017 Category: Urology & Nephrology Authors: Daisuke KATO , Hiromi TABUCHI , Satoshi UNO Source Type: research